Patricia LoRusso, D.O., medical director of Phase I Clinical Trials and Multidisciplinary Team Leader of Phase I Clinical Trials at the Barbara Ann Karmanos Cancer Institute, as well as professor of medicine at Wayne State University School of Medicine, is the principle corresponding author of an article currently posted on Clinical Cancer Research online. The article is part of a series of stories about Phase I clinical trials.

The article is entitled, “An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics.” She shares authorship with Scott A. Boerner, M.S., research assistant in internal medicine at the Karmanos Cancer Institute and Lesley Seymour, M.D., Ph.D., of the NCIC Clinical Trials Group at Queens University in Kingston, Ontario, Canada.

The Karmanos Cancer Institute has one of only 14 National Cancer Institute-funded Phase I programs in the country, and is the only such program in Michigan. Karmanos has played a part in obtaining FDA-approval for many cancer drugs that fight lung, breast and colorectal cancer, among others.

Click here to read the article in Clinical Cancer Research: